Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H18ClO3.Na |
Molecular Weight | 316.755 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[O-]C(=O)CCC(=O)C1=CC=C(C2CCCCC2)C(Cl)=C1
InChI
InChIKey=OFRBVEGXSAGHEW-UHFFFAOYSA-M
InChI=1S/C16H19ClO3.Na/c17-14-10-12(15(18)8-9-16(19)20)6-7-13(14)11-4-2-1-3-5-11;/h6-7,10-11H,1-5,8-9H2,(H,19,20);/q;+1/p-1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/4614821
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4614821
Bucloxic acid, a nonsteroidal anti-inflammatory agent, which was studied to treat the chronic glomerular nephropathy.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[A new nonsteroidal anti-inflammatory agent: bucloxic acid (804 CB)]. | 1974 Sep |
|
[Pharmacologic properties of a new, nonsteroidal anti-inflammatory agent, bucloxic acid (804 CB)]. | 1974 Sep |
|
Toxicological studies of bucloxic acid (804 CB). | 1974 Sep |
|
Study of possible teratogenicity of bucloxic acid (804 CB). | 1974 Sep |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4N04UQ84B2
Created by
admin on Fri Dec 15 18:07:36 GMT 2023 , Edited by admin on Fri Dec 15 18:07:36 GMT 2023
|
PRIMARY | |||
|
DTXSID20186476
Created by
admin on Fri Dec 15 18:07:36 GMT 2023 , Edited by admin on Fri Dec 15 18:07:36 GMT 2023
|
PRIMARY | |||
|
32808-52-9
Created by
admin on Fri Dec 15 18:07:36 GMT 2023 , Edited by admin on Fri Dec 15 18:07:36 GMT 2023
|
PRIMARY | |||
|
23663455
Created by
admin on Fri Dec 15 18:07:36 GMT 2023 , Edited by admin on Fri Dec 15 18:07:36 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD